Targeting PIM kinase as a therapeutic strategy in human hepatoblastoma

Increasing incidence coupled with poor prognosis and treatments that are virtually unchanged over the past 20 years have made the need for the development of novel therapeutics for hepatoblastoma imperative. PIM kinases have been implicated as drivers of tumorigenesis in multiple cancers, including...

Descripción completa

Detalles Bibliográficos
Autores principales: Stafman, Laura L., Mruthyunjayappa, Smitha, Waters, Alicia M., Garner, Evan F., Aye, Jamie M., Stewart, Jerry E., Yoon, Karina J., Whelan, Kimberly, Mroczek-Musulman, Elizabeth, Beierle, Elizabeth A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5978256/
https://www.ncbi.nlm.nih.gov/pubmed/29854306
http://dx.doi.org/10.18632/oncotarget.25205

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5978256/
https://www.ncbi.nlm.nih.gov/pubmed/29854306
http://dx.doi.org/10.18632/oncotarget.25205

Ejemplares similares